Nucleic acid biomarkers: optimizing strategies for discovery
Biomarkers, also referred to as molecular markers or signature molecules, play a crucial role in drug development and translational research. This webinar aims to provide a comprehensive understanding of the different types of biomarkers. We will explore how researchers in biologics discovery and development are effectively identifying and utilizing nucleic acid biomarkers through the application of qPCR and other genetic analysis tools.
What will you learn?
- The characteristics of a good biomarker
- The different types of biomarkers available
- How scientists are using biomarkers in their work
- The options for identifying nucleic acid biomarkers using qPCR HTS
Who this may interest?
- Biomedical scientists and translational researchers interested in using nucleic acid biomarkers for insights into basic biology, drug development or cell and gene therapy research.
Speaker
Dr. Steve Jackson
Senior Manager, Applications
Genetic Sciences Group, Thermo Fisher Scientific (MA, USA)
Dr Jackson has over 15 years of experience developing applications for genomic analysis technologies. As a senior member of the Applications Development team at Thermo Fisher Scientific, he helps develop solutions for the research and healthcare markets, leveraging varied technologies such as capillary electrophoresis, RT-PCR, digital PCR, next-generation sequencing and microarray analysis. Before Thermo Fisher Scientific, Steve worked at NanoString Technologies (WA, USA) running the Field Applications Scientist team. He was also an Acting Assistant Professor at the University of Washington, Department of Genome Sciences (WA, USA), investigating developmental genetics of Drosophila melanogaster.
In association with
This webinar was recorded on Thursday 28 March 2024